|Bid||17.00 x 100|
|Ask||19.62 x 100|
|Day's range||17.82 - 18.37|
|52-week range||10.75 - 23.01|
|PE ratio (TTM)||35.84|
|Earnings date||1 May 2018 - 7 May 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||20.90|
On a per-share basis, the Bethlehem, Pennsylvania-based company said it had net income of 12 cents. The diagnostic test maker posted revenue of $52 million in the period. For the year, the company reported ...
While the world’s attention turns to Pennsylvania on February 2nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1st for the 2018 Emerald Asset Management Groundhog Day Investment Forum.
Join Emerald Asset Management for the landmark 25th annual Emerald Groundhog Day Investment Forum on February 1st in Philadelphia. The Forum is the unofficial kick-off to the year
Orasure Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 36TH Annual J.P. Morgan Healthcare Conference. The conference will be simultaneously webcast over the Internet.
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced a succession plan for its President and Chief Executive Officer (“CEO”) and for its Chief Financial Officer and Chief Operating Officer. The Company also announced updated revenue guidance for the fourth quarter of 2017.
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OraSure Technologies, Inc. (NASDAQ:OSUR), Air Lease Corporation (NYSE:AL), Buckeye Partners L.P. (NYSE:BPL), Glatfelter (NYSE:GLT), Great Western Bancorp, Inc. (NYSE:GWB), and Trustmark Corporation (NASDAQ:TRMK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Orasure Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83.
Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.
After the completion of Shiel's acquisition, the medical lab is expected to expand Quest Diagnostics' (DGX) physician and patient service centers network in the New York-New Jersey area.